Table 1.
Clinicopathological features of the studied small cell lung cancer patients according to TRIT1 gene amplification status.
| Clinical Characteristics | Total (n = 39) |
TRIT1 Non-Amplified (n = 35) |
TRIT1 Amplified (n = 4) |
p Value * |
|---|---|---|---|---|
| Age years [median (range)] | 65 (49–84) | 65 (49–84) | 65 (55–71) | |
| Gender | ||||
| Female | 8 (20.5%) | 7 (20.0%) | 1 (25.0%) | 1.000 |
| Male | 31 (79.5%) | 28 (80.0%) | 3 (75.0%) | |
| Smoker | ||||
| Yes | 33 (84.6%) | 29 (82.9%) | 4 (100.0%) | 1.000 |
| No | 3 (7.7%) | 3 (8.6%) | 0 (0.0%) | |
| Unknown | 3 (7.7%) | 3 (8.6%) | 0 (0.0%) | |
| Stage | ||||
| I | 10 (25.6%) | 7 (20.0%) | 3 (75.0%) | 0.098 |
| II | 4 (10.3%) | 4 (11.4%) | 0 (0.0%) | |
| III | 11 (28.2%) | 10 (28.6%) | 1 (25.0%) | |
| IV | 14 (35.9%) | 14 (40.0%) | 0 (0.0%) | |
| Type of clinical disease | ||||
| Localized | 18 (46.2%) | 15 (42.9%) | 3 (75.0%) | 0.318 |
| Extensive | 21 (53.8%) | 20 (57.1%) | 1 (25.0%) |
* p-value represents Fisher’s exact test or X2.